A single center comparative retrospective study of in situ split plus portal vein ligation versus conventional two-stage hepatectomy for cholangiocellular carcinoma

References

• DeOliveira ML, Cunningham SC, Cameron JL, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245(5):755–762.
   PubMed Web of Science ®Google Scholar
• Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224(4):463–473; discussion 473–475.
   PubMed Web of Science ®Google Scholar
• Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557–588.
   PubMed Web of Science ®Google Scholar
• van Vugt JLA, Gaspersz MP, Coelen RJS, et al. The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinoma. HPB. 2018;20(1):83–92.
   PubMed Web of Science ®Google Scholar
• Khan SA, Davidson BR, Goldin RD, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut. 2012;61(12):1657–1669.
   PubMed Web of Science ®Google Scholar
• Sano T, Shimada K, Sakamoto Y, et al. Prognosis of perihilar cholangiocarcinoma: Hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus. Ann Surg Oncol. 2008;15(2):590–599.
   PubMed Web of Science ®Google Scholar
• Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273–1281.
   PubMed Web of Science ®Google Scholar
• Okusaka T, Nakachi K, Fukutomi A, et al. Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer. 2010;103(4):469–474.
   PubMed Web of Science ®Google Scholar
• Shindoh J, Truty MJ, Aloia TA, et al. Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg. 2013;216(2):201–209.
   PubMed Web of Science ®Google Scholar
• Kishi Y, Abdalla EK, Chun YS, et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg. 2009;250(4):540–548.
   PubMed Web of Science ®Google Scholar
• Sparrelid E, Gilg S, Brismar TB, et al. Rescue ALPPS is efficient and safe after failed portal vein occlusion in patients with colorectal liver metastases. Langenbecks Arch Surg. 2017;402(1):69–75.
   PubMed Web of Science ®Google Scholar
• Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990;107(5):521–527.
   PubMed Web of Science ®Google Scholar
• Nagino M, Kamiya J, Nishio H, et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;243(3):364–372.
   PubMed Web of Science ®Google Scholar
• Olthof PB, Aldrighetti L, Alikhanov R, et al. Portal vein embolization is associated with reduced liver failure and mortality in high-risk resections for perihilar cholangiocarcinoma. Ann Surg Oncol. 2020;27(7):2311–2318.
   PubMed Web of Science ®Google Scholar
• Abulkhir A, Limongelli P, Healey AJ, et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg. 2008;247(1):49–57.
   PubMed Web of Science ®Google Scholar
• Wicherts DA, de Haas RJ, Andreani P, et al. Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases. Br J Surg. 2010;97(2):240–250.
   PubMed Web of Science ®Google Scholar
• Simoneau E, Aljiffry M, Salman A, et al. Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases. HPB. 2012;14(7):461–468.
   PubMed Web of Science ®Google Scholar
• Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;255(3):405–414.
   PubMed Web of Science ®Google Scholar
• Lang H, de Santibañes E, Schlitt HJ, et al. 10th anniversary of ALPPS-lessons learned and quo vadis. Ann Surg. 2019;269(1):114–119.
   PubMed Web of Science ®Google Scholar
• Linecker M, Stavrou GA, Oldhafer KJ, et al. The ALPPS risk score: avoiding futile use of ALPPS. Ann Surg. 2016;264(5):763–771.
   PubMed Web of Science ®Google Scholar
• Linecker M, Björnsson B, Stavrou GA, et al. Risk adjustment in ALPPS is associated with a dramatic decrease in early mortality and morbidity. Ann Surg. 2017;266(5):779–786.
   PubMed Web of Science ®Google Scholar
• Truant S, Scatton O, Dokmak S, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): impact of the inter-stages course on morbi-mortality and implications for management. Eur J Surg Oncol. 2015;41(5):674–682.
   PubMed Web of Science ®Google Scholar
• Bednarsch J, Czigany Z, Sharmeen S, et al. ALPPS versus two-stage hepatectomy for colorectal liver metastases–a comparative retrospective cohort study. World J Surg Oncol. 2020;18(1):140.
   PubMed Web of Science ®Google Scholar
• Sandström P, Røsok BI, Sparrelid E, et al. ALPPS improves resectability compared with conventional two-stage hepatectomy in patients with advanced colorectal liver metastasis: results from a Scandinavian multicenter randomized controlled trial (LIGRO trial). Ann Surg. 2018;267(5):833–840.
   PubMed Web of Science ®Google Scholar
• Hasselgren K, Røsok BI, Larsen PN, et al. ALPPS improves survival compared with TSH in patients affected of CRLM: survival analysis from the randomized controlled trial LIGRO. Ann Surg. 2021;273(3):442–448.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yang Z, Zhang S, et al. Conventional two-stage hepatectomy or associating liver partitioning and portal vein ligation for staged hepatectomy for colorectal liver metastases? A systematic review and meta-analysis. Front Oncol. 2020;10:1391.
   PubMed Web of Science ®Google Scholar
• Mansour JC, Aloia TA, Crane CH, et al. Hilar cholangiocarcinoma: expert consensus statement. HPB. 2015;17(8):691–699.
   PubMed Web of Science ®Google Scholar
• Olthof PB, Coelen RJS, Wiggers JK, et al. High mortality after ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international ALPPS registry. HPB. 2017;19(5):381–387.
   PubMed Web of Science ®Google Scholar
• Nagino M, Kamiya J, Kanai M, et al. Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility. Surgery. 2000;127(2):155–160.
   PubMed Web of Science ®Google Scholar
• Li J, Moustafa M, Linecker M, et al. ALPPS for locally advanced intrahepatic cholangiocarcinoma: did aggressive surgery lead to the oncological benefit? An international multi-center study. Ann Surg Oncol. 2020;27(5):1372–1384.
   PubMed Web of Science ®Google Scholar
• Bednarsch J, Czigany Z, Lurje I, et al. The role of ALPPS in intrahepatic cholangiocarcinoma. Langenbecks Arch Surg. 2019;404(7):885–894.
   PubMed Web of Science ®Google Scholar
• Lee AJ, Chun YS. Intrahepatic cholangiocarcinoma: the AJCC/UICC 8th edition updates. Chin Clin Oncol. 2018;7(5):52.
   PubMed Web of Science ®Google Scholar
• Juntermanns B, Sotiropoulos GC, Radunz S, et al. Comparison of the sixth and the seventh editions of the UICC classification for perihilar cholangiocarcinoma. Ann Surg Oncol. 2013;20(1):277–284.
   PubMed Web of Science ®Google Scholar
• Vauthey JN, Chaoui A, Do KA, et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery. 2000;127(5):512–519.
   PubMed Web of Science ®Google Scholar
• Truant S, Oberlin O, Sergent G, et al. Remnant liver volume to body weight ratio > or =0.5%: a new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver. J Am Coll Surg. 2007;204(1):22–33.
   PubMed Web of Science ®Google Scholar
• Knoefel WT, Gabor I, Rehders A, et al. In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection. Br J Surg. 2013;100(3):388–394.
   PubMed Web of Science ®Google Scholar
• Lehwald-Tywuschik N, Vaghiri S, Schulte Am Esch J, et al. In situ split plus portal vein ligation (ISLT) – a salvage procedure following inefficient portal vein embolization to gain adequate future liver remnant volume prior to extended liver resection. BMC Surg. 2020;20(1):63.
   PubMed Web of Science ®Google Scholar
• Balzan S, Belghiti J, Farges O, et al. The “50–50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242(6):824–828; discussion 828–829.
   PubMed Web of Science ®Google Scholar
• Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the international study group of liver surgery (ISGLS). Surgery. 2011;149(5):713–724.
   PubMed Web of Science ®Google Scholar
• Dindo D, Demartines N, Clavien P-A. Classification of surgical complications. Ann Surg. 2004;240(2):205–213.
   PubMed Web of Science ®Google Scholar
• Nagino M, Ebata T, Yokoyama Y, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 2013;258(1):129–140.
   PubMed Web of Science ®Google Scholar
• Balci D, Sakamoto Y, Li J, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure for cholangiocarcinoma. Int J Surg. 2020;82S:97–102.
   PubMedGoogle Scholar
• Wiggers JK, Groot Koerkamp B, Cieslak KP, et al. Postoperative mortality after liver resection for perihilar cholangiocarcinoma: development of a risk score and importance of biliary drainage of the future liver remnant. J Am Coll Surg. 2016;223(2):321–331.e1.
   PubMed Web of Science ®Google Scholar
• van Keulen A-M, Buettner S, Besselink MG, et al. Surgical morbidity in the first year after resection for perihilar cholangiocarcinoma. HPB. 2021;23(10):1607–1614.
   PubMed Web of Science ®Google Scholar
• Ribero D, Zimmitti G, Aloia TA, et al. Preoperative cholangitis and future liver remnant volume determine the risk of liver failure in patients undergoing resection for hilar cholangiocarcinoma. J Am Coll Surg. 2016;223(1):87–97.
   PubMed Web of Science ®Google Scholar
• Glantzounis GK, Tokidis E, Basourakos S-P, et al. The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review. Eur J Surg Oncol. 2017;43(1):32–41.
   PubMed Web of Science ®Google Scholar
• Oldhafer KJ, Stavrou GA, van Gulik TM, et al. ALPPS ALPPS-where do we stand, where do we go?: Eight recommendations from the first international expert meeting. Ann Surg. 2016;263(5):839–841.
   PubMed Web of Science ®Google Scholar
• Schadde E, Ardiles V, Robles-Campos R, et al. Early survival and safety of ALPPS: first report of the international ALPPS registry. Ann Surg. 2014;260(5):829–836; discussion 836–838.
   PubMed Web of Science ®Google Scholar
• Schadde E, Raptis DA, Schnitzbauer AA, et al. Prediction of mortality after ALPPS stage-1: an analysis of 320 patients from the international ALPPS registry. Ann Surg. 2015;262(5):780–785; discussion 785–786.
   PubMed Web of Science ®Google Scholar
• Lang H, de Santibanes E, Clavien PA. Outcome of ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international ALPPS registry. HPB. 2017;19(5):379–380.
   PubMed Web of Science ®Google Scholar
• Nagino M. Value of ALPPS in surgery for Klatskin tumours. Br J Surg. 2019;106(12):1574–1575.
   PubMed Web of Science ®Google Scholar
• Alvarez FA, Ardiles V, de Santibañes M, et al. Associating liver partition and portal vein ligation for staged hepatectomy offers high oncological feasibility with adequate patient safety: a prospective study at a single center. Ann Surg. 2015;261(4):723–732.
   PubMed Web of Science ®Google Scholar
• Petrowsky H, Györi G, de Oliveira M, et al. Is partial-ALPPS safer than ALPPS? A single-center experience. Ann Surg. 2015;261(4):e90–e92.
   PubMed Web of Science ®Google Scholar
• Huang H-C, Bian J, Bai Y, et al. Complete or partial split in associating liver partition and portal vein ligation for staged hepatectomy: a systematic review and meta-analysis. World J Gastroenterol. 2019;25(39):6016–6024.
   PubMed Web of Science ®Google Scholar